GlassScriptPhysician profile
Lauren Michele Wright
NPI 1992142350
$4,836.79
in general payments reported to CMS, 2019-2025
18 companies · $1,034 in 2025
The $1,034 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,292 · 2020: $174 · 2021: $266 · 2022: $23.43 · 2023: $102 · 2024: $947 · 2025: $1,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065 · Education: $17.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,065.12 |
| Education | $17.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $1,733.00 | 2019 | |
| Genentech USA, INC. | $659.49 | 2020-2025 | Vabysmo, Susvimo |
| Regeneron Healthcare Solutions, INC. | $627.05 | 2019-2025 | Eylea Hd, Eylea |
| Alcon Vision LLC | $520.37 | 2019-2024 | Ngenuity |
| Harrow Eye, LLC | $428.07 | 2025 | Triesence, Vevye |
| Genentech, INC. | $164.33 | 2025 | Vabysmo |
| Dutch Ophthalmic, USA | $140.42 | 2024 | Eva, Combined Machine, Tissueblue |
| Alimera Sciences, INC. | $121.92 | 2019 | |
| Abbvie INC. | $79.70 | 2025 | |
| Apellis Pharmaceuticals, INC. | $70.19 | 2023-2024 | Syfovre |
| Heidelberg Engineering, INC. | $68.13 | 2019 | |
| Ani Pharmaceuticals, INC. | $56.56 | 2025 | Iluvien, Yutiq |
| Astellas Pharma US INC | $50.17 | 2024-2025 | Izervay |
| Biogen, INC. | $46.64 | 2024 | Byooviz |
| Novartis Pharmaceuticals Corporation | $23.48 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $20.75 | 2024 | Xipere, Retisert, Visudyne |
| Amgen INC. | $15.28 | 2025 | Pavblu |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.